MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 56 filers reported holding MEDIVATION INC in Q3 2016. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $465,000 | -86.9% | 7,712 | -90.0% | 0.03% | -86.7% |
| Q1 2016 | $3,560,000 | +565.4% | 77,435 | +599.3% | 0.20% | +554.8% |
| Q4 2015 | $535,000 | -91.8% | 11,073 | -92.8% | 0.03% | -90.6% |
| Q3 2015 | $6,534,000 | +216.4% | 153,743 | +750.1% | 0.33% | +226.7% |
| Q2 2015 | $2,065,000 | +178.3% | 18,086 | +214.8% | 0.10% | +180.6% |
| Q1 2015 | $742,000 | -82.4% | 5,745 | -86.4% | 0.04% | -84.1% |
| Q4 2014 | $4,213,000 | +378.8% | 42,298 | +375.1% | 0.23% | +320.4% |
| Q3 2014 | $880,000 | +64.5% | 8,903 | +28.3% | 0.05% | +68.8% |
| Q2 2014 | $535,000 | – | 6,939 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,244,519 | $221,916,000 | 86.32% |
| BB BIOTECH AG | 1,429,706 | $141,355,000 | 5.75% |
| Selkirk Management LLC | 64,300 | $6,357,000 | 4.00% |
| Eventide Asset Management | 275,300 | $27,219,000 | 3.80% |
| HealthCor Management, L.P. | 525,000 | $51,907,000 | 2.67% |
| Quotient Investors, LLC | 110,856 | $10,960,000 | 2.39% |
| Orbimed Advisors | 2,273,000 | $224,732,000 | 2.35% |
| BENDER ROBERT & ASSOCIATES | 26,478 | $2,618,000 | 1.82% |
| Bain Capital Public Equity Management, LLC | 623,990 | $61,694,000 | 1.58% |
| Gerry Farber, LLC | 12,200 | $1,206,000 | 1.57% |